Herceptin 150 mg powder for concentrate for solution for infusion, Perjeta 420 mg concentrate for solution for infusion
MO29406
Phase 3 small_molecule active
Quick answer
Herceptin 150 mg powder for concentrate for solution for infusion, Perjeta 420 mg concentrate for solution for infusion for Solid Malignant Tumors is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Solid Malignant Tumors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active